Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tyme Technologies (TYME)

Tyme Technologies (TYME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,505
  • Shares Outstanding, K 172,207
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,630 K
  • 60-Month Beta 0.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.72
Trade TYME with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings $-0.04 on 08/09/22
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2330 +33.35%
on 09/07/22
0.3500 -11.23%
on 08/17/22
-0.0393 (-11.23%)
since 08/16/22
3-Month
0.2330 +33.35%
on 09/07/22
0.4050 -23.28%
on 07/05/22
+0.0607 (+24.28%)
since 06/16/22
52-Week
0.2187 +42.07%
on 05/12/22
1.1400 -72.75%
on 09/27/21
-0.7293 (-70.13%)
since 09/16/21

Most Recent Stories

More News
Pre-Market Brief: Stocks Slump As Recessionary Fears Grow

September S&P 500 futures (ESU22) are trending down -1.02% this morning after three major US benchmark indices resumed declines during the regular session as a variety of economic data failed to change...

ESU22 : 3,871.24s (-0.79%)
FDX : 271.75 (+0.59%)
AMZN : 179.54 (+1.30%)
ADBE : 472.90 (+1.29%)
UPS : 148.87 (+2.41%)
SYRS : 5.14 (+3.01%)
TYME : 0.3107 (+8.07%)
GE : 162.62 (+8.28%)
IHG : 100.13 (+1.89%)
Syros and Tyme Technologies Announce Stockholder Approval of Merger

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and Tyme Technologies, Inc. (NASDAQ:TYME) today announced the results of the special...

SYRS : 5.14 (+3.01%)
TYME : 0.3107 (+8.07%)
TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TYME Technologies, Inc. (NasdaqCM: TYME) to...

TYME : 0.3107 (+8.07%)
SYRS : 5.14 (+3.01%)
TYME TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

TYME : 0.3107 (+8.07%)
SYRS : 5.14 (+3.01%)
Biotech Stock Roundup: VRTX's Regulatory Update, TYME Gains on Acquisition & More

Regulatory and other updates from Vertex (VRTX) and TYME are a few key highlights from the biotech sector during the past week.

VRTX : 404.91 (+1.25%)
NVAX : 4.19 (+2.95%)
SYRS : 5.14 (+3.01%)
AMLX : 1.9500 (-1.52%)
TYME : 0.3107 (+8.07%)
SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Syros Pharmaceuticals,...

SYRS : 5.14 (+3.01%)
TYME : 0.3107 (+8.07%)
TYME TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TYME Technologies, Inc. (NasdaqCM: TYME) to...

TYME : 0.3107 (+8.07%)
SYRS : 5.14 (+3.01%)
Shareholder Alert: Ademi LLP investigates whether TYME Technologies, Inc. has obtained a Fair Price in its transaction with Syros

/PRNewswire/ -- Ademi LLP is investigating TYME (NASDAQ:TYME) for possible breaches of fiduciary duty and other violations of law in its transaction with Syros....

TYME : 0.3107 (+8.07%)
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and TYME Technologies, Inc. (NASDAQ:TYME), today announced that the companies have entered...

SYRS : 5.14 (+3.01%)
TYME : 0.3107 (+8.07%)
TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results

-- $84.0 million in cash and marketable securities as of March 31, 2022 --...

TYME : 0.3107 (+8.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize in the body's immune system to treat diseases. Tyme Technologies, Inc. is headquartered in New York.

See More

Key Turning Points

3rd Resistance Point 0.3521
2nd Resistance Point 0.3336
1st Resistance Point 0.3221
Last Price 0.3107
1st Support Level 0.2921
2nd Support Level 0.2736
3rd Support Level 0.2621

See More

52-Week High 1.1400
Fibonacci 61.8% 0.7881
Fibonacci 50% 0.6794
Fibonacci 38.2% 0.5706
Last Price 0.3107
52-Week Low 0.2187

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar